Vimarsana
Biggest News Aggregation in the World

Page 14 - Rhinitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rhinitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rhinitis Today - Breaking & Trending Today

Specific variant of the HLA-DPB1 gene linked with poor response to allergen immunotherapy - Vimarsana News

Specific variant of the HLA-DPB1 gene linked with poor response to allergen immunotherapy

Although sublingual immunotherapy (SLIT) has become an effective treatment option for many allergies, about 20-30% of patients don’t respond to SLIT for Japanese cedar pollinosis–a highly common disease.

Schoolchildren in Hong Kong surveyed on the prevalence and impact of allergic diseases - Vimarsana News

Schoolchildren in Hong Kong surveyed on the prevalence and impact of allergic diseases

A collaborative study by the Department of Social Work and Social Administration, the University of Hong Kong andthe Department of Paediatrics and Adolescent Medicine, United Christian Hospital

DelveInsight Business Research, LLP: Allergic Rhinitis Market Is Contemplated to Advance at a CAGR of 2.5% in the 7MM for the Study Period of 2018-30, Asserts DelveInsight - Vimarsana News

DelveInsight Business Research, LLP: Allergic Rhinitis Market Is Contemplated to Advance at a CAGR of 2.5% in the 7MM for the Study Period of 2018-30, Asserts DelveInsight

- Allergic Rhinitis Market is anticipated to grow owing to factors such as the incoming of novel and emerging potential Allergic Rhinitis treatment therapies and the contribution of pharma giants

Research and Markets: Europe Allergic Rhinitis Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares - Vimarsana News

Research and Markets: Europe Allergic Rhinitis Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares

The "Europe Allergic Rhinitis Market and Competitive Landscape 2021" report has been added to ResearchAndMarkets.com's offering. The latest research Europe Allergic Rhinitis Market and Competitive

Asthma Treatment Does Not Raise Risk of Neuropsychiatric Disease - Vimarsana News

Asthma Treatment Does Not Raise Risk of Neuropsychiatric Disease

A large study of older adults revealed no association between increased risk of neuropsychiatric disease and use of leukotriene receptor antagonists.